The Use of an Artificial Intelligence Platform OpenEvidence to Augment Clinical Decision-Making for Primary Care Physicians
Journal of Primary Care & Community Health · 2025-12 · 16
DOI: 10.1177/21501319251332215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Primary Care & Community Health, online erschienen am 16.04.2025. Verfasst von Ryan T Hurt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Clinical Decision-Making, Physicians, Primary Care. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Artificial intelligence (AI) platforms can potentially enhance clinical decision-making (CDM) in primary care settings. OpenEvidence (OE), an AI tool, draws from trusted sources to generate evidence-based medicine (EBM) recommendations to address clinical questions. However, its effectiveness in real-world primary care cases remains unknown.
Objective
To evaluate the performance of OE in providing EBM recommendations for five common chronic conditions in primary care: hypertension, hyperlipidemia, diabetes mellitus type 2, depression, and obesity.
Methods
Five patient cases were retrospectively analyzed. Physicians posed specific clinical questions, and OE responses were evaluated on clarity, relevance, evidence support, impact on CDM, and overall satisfaction. Four independent physicians provided ratings using a 0 to 4 scale.
Results
OE provided accurate, evidence-based recommendations in all cases, aligning with physician plans. OE was scored on a scale of zero to four, where zero was very unclear, and four was very clear. Mean scores across cases were clarity (3.55 ± 0.60), relevance (3.75 ± 0.44), support (3.35 ± 0.49), and satisfaction (3.60 ± 0.60). However, the impact on CDM was limited (1.95 ± 1.05), as OE primarily reinforced rather than modified plans.
Conclusion
OE was rated high in clarity, relevance, and evidence-based support, reinforcing physician decisions in common chronic conditions. While the impact on CDM was minimal due to the study’s retrospective nature, OE shows promise in augmenting the primary care physician. Prospective trials are needed to evaluate its utility in complex cases and multidisciplinary settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Elizabeth A Gilman, Ivana T Croghan, Manpreet S Mundi
Zitieren
APA
Hurt, R. T., Stephenson, C. R., Gilman, E. A., Aakre, C. A., Croghan, I. T., Mundi, M. S., Ghosh, K., & Edakkanambeth Varayil, J. (2025). The Use of an Artificial Intelligence Platform OpenEvidence to Augment Clinical Decision-Making for Primary Care Physicians. Journal of Primary Care & Community Health, 16. https://doi.org/10.1177/21501319251332215
Vancouver
Hurt RT, Stephenson CR, Gilman EA, Aakre CA, Croghan IT, Mundi MS, et al. The Use of an Artificial Intelligence Platform OpenEvidence to Augment Clinical Decision-Making for Primary Care Physicians. Journal of Primary Care & Community Health. 2025;16. doi:10.1177/21501319251332215
BibTeX
@article{Hurt2025,
author = {Hurt, Ryan T and Stephenson, Christopher R and Gilman, Elizabeth A and Aakre, Christopher A and Croghan, Ivana T and Mundi, Manpreet S and Ghosh, Karthik and Edakkanambeth Varayil, Jithinraj},
title = {The Use of an Artificial Intelligence Platform OpenEvidence to Augment Clinical Decision-Making for Primary Care Physicians},
journal = {Journal of Primary Care & Community Health},
year = {2025},
volume = {16},
doi = {10.1177/21501319251332215}
}
EUVIMED